Acadian Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.28M Sell
13,827
-55,832
-80% -$5.61M ﹤0.01% 1088
2025
Q4
$7.11M Buy
69,659
+69,170
+14,145% +$6.19M 0.01% 562
2025
Q3
$30K Buy
+489
New +$26.6K ﹤0.01% 1721
2024
Q4
Sell
-10,969
Closed -$251K 1828
2024
Q3
$251K Buy
+10,969
New +$310K ﹤0.01% 1288
2023
Q2
Sell
-1,590
Closed -$37K 1796
2023
Q1
$37K Buy
+1,590
New +$45.4K ﹤0.01% 1561

Other funds holding GH

Acadian Asset Management's GH Position: Q1 2026 in Review

Acadian Asset Management reduced its Guardant Health (GH) stake by 80% in Q1 2026, selling an estimated $5.61M and leaving 13,827 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

Acadian Asset Management first reported a position in GH in Q1 2023 and has held it in 5 quarters since. The position peaked at $7.11M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Acadian Asset Management held 13,827 shares of Guardant Health worth $1.28M as of Q1 2026.
  • Acadian Asset Management sold 55,832 Guardant Health shares in Q1 2026, an estimated $5.61M.
  • Guardant Health made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1088 holding.
  • Acadian Asset Management first reported a position in Guardant Health in Q1 2023 and has held it in 5 quarters since.
  • Acadian Asset Management's Guardant Health position peaked at $7.11M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.